Company
Every investor coverage indicates participated in a round MGC Pharmaceuticals raised.
Companies MGC Pharmaceuticals acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming MGC Pharmaceuticals. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of manufacturing items: a ventilation grant program reopens, MGC Pharma reports Long Covid trial results, CSIRO and CSCRC projects win iAwards, Spiral Blue completes satellite integration, and AML3D raises capital.
Also 3dprint.com
Techboard's annual report finds Australian early-stage startup funding passed $10 billion in FY21, up 64%, while WA companies attracted just $50 million, with ASX raises dominating and female founders' funding share falling.